Aprea Therapeutics, Inc.

( )
APRE PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 1.53%141.900.7%$2298.59m
PFEPfizer Inc. 1.39%35.010.9%$1483.30m
MRKMerck & Co., Inc. 1.18%81.290.7%$1362.98m
ABBVAbbVie, Inc. 2.57%77.502.3%$1259.47m
BMYBristol-Myers Squibb Co. 1.84%58.801.0%$1178.25m
LLYEli Lilly & Co. 1.46%143.361.1%$885.50m
NVSNovartis AG 0.28%86.040.2%$306.60m
AZNAstraZeneca Plc -1.51%43.631.2%$297.00m
GSKGlaxoSmithKline Plc 0.21%38.000.2%$258.86m
SNYSanofi -1.39%45.480.2%$174.48m
NVONovo Nordisk A/S -1.04%60.050.1%$169.99m
FTSVForty Seven, Inc. 0.05%95.510.0%$152.45m
BHCBausch Health Cos., Inc. 4.31%15.240.0%$101.77m
RGENRepligen Corp. 2.55%100.717.1%$73.73m
RETAReata Pharmaceuticals, Inc. 0.00%138.293.4%$66.79m

Company Profile

Aprea Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wenji Bao in 2002 and is headquartered in Boston, MA.